Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21859 | 402 | 30.0 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
1364 | 2 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MURAMYL DIPEPTIDE//IMMUNOLOGY | 8243 |
21859 | 1 | BY ACTIVATED MACROPHAGES//IMPLANTED IN NUDE MICE//MACROPHAGE HUMAN | 402 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BY ACTIVATED MACROPHAGES | authKW | 151916 | 0% | 100% | 2 |
2 | IMPLANTED IN NUDE MICE | authKW | 151916 | 0% | 100% | 2 |
3 | MACROPHAGE HUMAN | authKW | 151916 | 0% | 100% | 2 |
4 | NONSPECIFIC ESTERASE ASSAY | authKW | 151916 | 0% | 100% | 2 |
5 | TUMORCYTOTOXICITY | authKW | 151916 | 0% | 100% | 2 |
6 | IN 111 COLLOID | authKW | 101276 | 0% | 67% | 2 |
7 | CYTOKINE BIOL SECT | address | 86308 | 1% | 23% | 5 |
8 | ACTIVATED KILLER MACROPHAGE | authKW | 75958 | 0% | 100% | 1 |
9 | ANTI TUMOUR CELL THERAPY | authKW | 75958 | 0% | 100% | 1 |
10 | AUTOLOGOUS ACTIVATED MACROPHAGES | authKW | 75958 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 5217 | 54% | 0% | 218 |
2 | Hematology | 1056 | 16% | 0% | 65 |
3 | Biochemical Research Methods | 610 | 14% | 0% | 55 |
4 | Cell Biology | 402 | 18% | 0% | 71 |
5 | Medicine, Research & Experimental | 258 | 10% | 0% | 42 |
6 | Oncology | 167 | 12% | 0% | 50 |
7 | Medical Laboratory Technology | 22 | 1% | 0% | 6 |
8 | Veterinary Sciences | 8 | 3% | 0% | 11 |
9 | Transplantation | 6 | 1% | 0% | 5 |
10 | Pathology | 5 | 2% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CYTOKINE BIOL SECT | 86308 | 1% | 23% | 5 |
2 | CLIN IMMUNOL S PEDIAT | 75958 | 0% | 100% | 1 |
3 | FOOD DRUG ADM BIOL EVALUAT | 75958 | 0% | 100% | 1 |
4 | FREDERICK CANC DEV IRSP | 75958 | 0% | 100% | 1 |
5 | LEADINGEDGE DRUG DISCOVERY DEV DIABET | 75958 | 0% | 100% | 1 |
6 | RECH HEMATOL IMMUNOTHER IE CANC | 75958 | 0% | 100% | 1 |
7 | SECT ONCOL CELLULAR PATHOLTUMOR TARGETING GRP | 75958 | 0% | 100% | 1 |
8 | ST BARTHOLMEWS ROYAL LONDON MED DENT | 75958 | 0% | 100% | 1 |
9 | TRANSLAT GENOM SECT | 75958 | 0% | 100% | 1 |
10 | VL KOMAROV MT TAIGA STN | 75958 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY | 16216 | 2% | 2% | 9 |
2 | JOURNAL OF IMMUNOLOGICAL METHODS | 15245 | 11% | 0% | 44 |
3 | RESEARCH IN IMMUNOLOGY | 6826 | 2% | 1% | 9 |
4 | JOURNAL OF LEUKOCYTE BIOLOGY | 5756 | 6% | 0% | 23 |
5 | IMMUNOBIOLOGY | 4675 | 3% | 0% | 14 |
6 | CELLULAR IMMUNOLOGY | 2475 | 4% | 0% | 16 |
7 | ACTA PAEDIATRICA BELGICA | 1897 | 0% | 3% | 1 |
8 | PLASMA THERAPY & TRANSFUSION TECHNOLOGY | 1165 | 0% | 1% | 2 |
9 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 1107 | 2% | 0% | 8 |
10 | CRC CRITICAL REVIEWS IN IMMUNOLOGY | 1068 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LESIMPLE, T , MOISAN, A , TOUJAS, L , (1998) AUTOLOGOUS HUMAN MACROPHAGES AND ANTI-TUMOUR CELL THERAPY.RESEARCH IN IMMUNOLOGY. VOL. 149. ISSUE 7-8. P. 663 -671 | 29 | 51% | 19 |
2 | ANDREESEN, R , HENNEMANN, B , KRAUSE, SW , (1998) ADOPTIVE IMMUNOTHERAPY OF CANCER USING MONOCYTE-DERIVED MACROPHAGES: RATIONALE, CURRENT STATUS, AND PERSPECTIVES.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 64. ISSUE 4. P. 419 -426 | 27 | 40% | 69 |
3 | BENNETT, S , BREIT, SN , (1994) VARIABLES IN THE ISOLATION AND CULTURE OF HUMAN MONOCYTES THAT ARE OF PARTICULAR RELEVANCE TO STUDIES OF HIV.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 56. ISSUE 3. P. 236-240 | 19 | 66% | 45 |
4 | QUILLIEN, V , MOISAN, A , LESIMPLE, T , LEBERRE, C , TOUJAS, L , (2001) BIODISTRIBUTION OF (111)INDIUM-LABELED MACROPHAGES INFUSED INTRAVENOUSLY IN PATIENTS WITH RENAL CARCINOMA.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 50. ISSUE 9. P. 477 -482 | 13 | 72% | 7 |
5 | HENNEMANN, B , BECKMANN, G , EICHELMANN, A , REHM, A , ANDREESEN, R , (1998) PHASE I TRIAL OF ADOPTIVE IMMUNOTHERAPY OF CANCER PATIENTS USING MONOCYTE-DERIVED MACROPHAGES ACTIVATED WITH INTERFERON GAMMA AND LIPOPOLYSACCHARIDE.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 45. ISSUE 5. P. 250-256 | 13 | 65% | 34 |
6 | ANDREESEN, R , BRUGGER, W , SCHEIBENBOGEN, C , KREUTZ, M , LESER, HG , REHM, A , LOHR, GW , (1990) SURFACE PHENOTYPE ANALYSIS OF HUMAN MONOCYTE TO MACROPHAGE MATURATION.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 47. ISSUE 6. P. 490-497 | 17 | 52% | 152 |
7 | KRAUSE, SW , ZAISS, M , KREUTZ, M , ANDREESEN, R , (2001) ACTIVATION OF LYMPHOCYTES INHIBITS HUMAN MONOCYTE TO MACROPHAGE DIFFERENTIATION.IMMUNOBIOLOGY. VOL. 203. ISSUE 5. P. 709-724 | 15 | 47% | 2 |
8 | FARADJI, A , BOHBOT, A , SCHMITTGOGUEL, M , SIFFERT, JC , DUMONT, S , WIESEL, ML , PIEMONT, Y , EISCHEN, A , BERGERAT, JP , BARTHOLEYNS, J , ET AL (1994) LARGE-SCALE ISOLATION OF HUMAN BLOOD MONOCYTES BY CONTINUOUS-FLOW CENTRIFUGATION LEUKAPHERESIS AND COUNTERFLOW CENTRIFUGATION ELUTRIATION FOR ADOPTIVE CELLULAR IMMUNOTHERAPY IN CANCER-PATIENTS.JOURNAL OF IMMUNOLOGICAL METHODS. VOL. 174. ISSUE 1-2. P. 297-309 | 12 | 67% | 38 |
9 | KRAUSE, SW , REHLI, M , ANDREESEN, R , (2002) ISOLATION, CHARACTERIZATION AND CULTIVATION OF HUMAN MONOCYTES AND MACROPHAGES.IMMUNOLOGY OF INFECTION, SECOND EDITION. VOL. 32. ISSUE . P. 767-785 | 11 | 58% | 0 |
10 | KRAUSE, SW , KREUTZ, M , ANDREESEN, R , (1998) ISOLATION, CHARACTERIZATION AND CULTIVATION OF HUMAN MONOCYTES AND MACROPHAGES.METHODS IN MICROBIOLOGY, VOL 25. VOL. 25. ISSUE . P. 663-684 | 12 | 60% | 5 |
Classes with closest relation at Level 1 |